What melanotan actually is, and where the line runs

The name shows up in two places that could not be further apart. In one, it's a prescription drug a dermatologist implants under the skin of patients with a rare light disorder. In the other, it's a vial or a nasal spray bought from a stranger online, marketed with the promise of a tan without the beach. Same root word, same underlying biology, wildly different worlds. It's worth knowing which is which before the word means anything to you.

The hormone it copies

Your body already makes a molecule that tells your skin to darken. It's called alpha-melanocyte-stimulating hormone, alpha-MSH for short, and it works by landing on a receptor called MC1R that sits on the surface of your melanocytes, the pigment cells in your skin. When alpha-MSH binds there, those cells make more eumelanin, the darker pigment. Sunlight is the usual trigger for this whole cascade. That's what a tan is: a stress response, your skin building pigment after UV damage has already started.

Melanotan is a lab-made copy of that signal. The idea, decades old now, was elegant on paper. If you could switch on the pigment pathway with a peptide instead of with ultraviolet light, you might darken skin without the DNA damage that makes sun exposure risky in the first place. That's the theory. The two compounds that came out of it went in very different directions.

The one with a label

Melanotan I, known now as afamelanotide, is a real drug with a real approval. In 2019 the FDA cleared it under the brand name Scenesse, and its job is narrow. It's for adults with erythropoietic protoporphyria, a rare inherited condition where sunlight causes severe pain because a faulty enzyme lets a light-sensitive molecule build up in the skin. For those patients, more pigment buys more time outdoors before the pain starts. In the trials, that difference was measured in hours of tolerable light, not in cosmetics.

Two details matter here. It's a synthetic analog of that natural alpha-MSH signal, delivered as an implant placed by a clinician, tracked, and prescribed for a specific diagnosis. It was the first medicine ever approved for that disease. None of that is a tanning product, and it was never studied or sold as one.

The one without

Melanotan II is the other branch, and it lives entirely outside that system. It's a more potent, less selective cousin, and it's the one being sold as a tanning shortcut. No regulator has approved it for human use. It's banned as a cosmetic in the United States, the UK, Australia, Denmark, and beyond, which hasn't stopped an online trade in unlabeled vials and nasal sprays. A 2025 survey reported that roughly one in five British adults had tried an injectable or inhaled tanning product of this kind. Dermatologists have been raising the alarm about the trend spreading on social media.

Being less selective is the crux of the problem. Where afamelanotide was engineered and tested for a defined use, Melanotan II reaches receptors beyond the ones involved in pigment, which is why the reported effects run well past a tan: nausea, vomiting, and, more troubling, moles that darken or change. Because the supply is unregulated, there's also no way to know what's actually in a given vial. Case reports in the medical literature have described changing moles and, in one instance, a melanoma of the mouth in a nasal-spray user. The through-line in every regulator's warning is the same: this has not been tested for safety, and nobody can tell you what it does over years.

The belief worth naming

The most persistent idea around Melanotan II is that a peptide tan somehow protects you, that darker skin means fewer burns and therefore less risk. Research into how people use it keeps finding that assumption, and it's the part that deserves the most skepticism. Extra pigment is not the same thing as safety, the long-term effects are genuinely unknown, and the people who study skin cancer are the ones sounding the least reassured.

So the useful frame is the one that holds for the whole peptide aisle. A shared name can hide a real divide. One melanocortin peptide is a narrow, supervised medicine for a rare disease. The other is an unregulated product a lot of health authorities have specifically told people to avoid. Knowing that the two are not interchangeable is most of what there is to know.

---

This post is educational and general in nature. It is not medical advice. For guidance about your own health, talk to a qualified clinician.